Towards Healthcare
Protein Chip Market to Rise at 7.78% till 2035

Protein Chip Market Gains Momentum from Biomarker Demand

According to forecasts, the global protine chip market will grow from USD 2.36 billion in 2025 to USD 4.98 billion by 2035, with an expected CAGR of 7.78%.The market is driven by the rising demand for protein chips for diagnostics and personalized medicine applications. North America maintained a stronghold on the global market due to the strong presence of key industry players.

  • Last Updated: 04 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The protein chip market stands at USD 2.54 billion in 2026 and is expected to reach USD 4.98 billion by 2035, growing at a CAGR of 7.78% from 2025 to 2035.

North America is leading the protein chip market share by 42% due to advanced research infrastructure, high investment in proteomics and personalized medicine, and the region advanced infrastructure.

Some key players include Thermo Fisher Scientific, Agilent Technologies, RayBiotech RayBiotech Life, R&D Systems (Bio-Techne), Sigma-Aldrich Merck KGaA (array substrates, reagents), EDM Millipore Merck (bioassays and consumables), and Luminex Corporation (bead-based multiplex assays), among others.

The protein chip market is the global industry that produces devices designed for convenient, precise insulin delivery in diabetes management. These pens replace traditional vials and syringes, offering accurate dosage, portability, and user-friendly administration for diabetic patients.